Molson Coors Brewing Co. (TAP)

54.49
0.79 1.50
NYSE : Consumer Non-Durables
Prev Close 53.70
Open 53.64
Day Low/High 53.39 / 54.57
52 Wk Low/High 52.36 / 71.04
Volume 1.60M
Avg Volume 1.51M
Exchange NYSE
Shares Outstanding 196.19M
Market Cap 11.78B
EPS 5.20
P/E Ratio 12.19
Div & Yield 1.64 (2.99%)

Latest News

Cannabis Enters Its Most Challenging Stage for Investors and Traders

Not to be outcome by a unicorn company, the unicorn sector of the markets, cannabis, is unleashing a blitzkrieg of news this morning. On the acquisition side, Cresco Labs is buying Origin House (CannaRoyalty) this morning for a small premium. It app...

7 Indirect Stock Plays on the Cannabis Sector

7 Indirect Stock Plays on the Cannabis Sector

Investors can gain exposure to the high-flying cannabis industry without taking on undue risks.

Tap Into This Buying Opportunity

Tap Into This Buying Opportunity

Molson Coors is now cheap enough and healthy enough to be a good stock to own.

Why Market Manipulation by the Fed Is a Bad Idea; A Look at Twilio: Market Recon

Why Market Manipulation by the Fed Is a Bad Idea; A Look at Twilio: Market Recon

A shift in the way the central bank manages its balance sheet is dangerous.

The Week Ahead: Inflation, Retail Sales and 13 Key Earnings Reports to Watch

The Week Ahead: Inflation, Retail Sales and 13 Key Earnings Reports to Watch

Nvidia and Coca-Cola are just two names set to report. Here's what to key in on.

Jim Cramer: Bezos, Amazon, and Next Week's Game Plan

Jim Cramer: Bezos, Amazon, and Next Week's Game Plan

Next week we'll be at the tail end of earnings season. It's been a blast, at least until this past week when we got some iffy news about trade.

Chart of the Day, Part 2: A Closer Look at Constellation's Big Cannabis Bet

Chart of the Day, Part 2: A Closer Look at Constellation's Big Cannabis Bet

Canopy Growth's smoking engine won't necessarily ensure smooth sailing for Constellation.

Jim Cramer: Constellation Brands Continues to Look Intriguing

Jim Cramer: Constellation Brands Continues to Look Intriguing

Even with its 12% stock decline on Wednesday, Constellation Brands is more intriguing than it was yesterday.

Real Money Goes Behind the Scenes of the Budding Cannabis Industry

Real Money Goes Behind the Scenes of the Budding Cannabis Industry

In the interest of due diligence, we went and took a close look at the ground floor of the newest investment craze.

Who Hasn't Crashed the Cannabis Party Yet?

Who Hasn't Crashed the Cannabis Party Yet?

Establishing who the stragglers are and what impact they might have in the future is the key at this point.

Tilray Is Now a Top-Tier Cannabis Play

Tilray Is Now a Top-Tier Cannabis Play

I'd be most interested in buying this name after a cap raise which I expect in the first quarter of 2019.

Chart of the Day, Part 2: Tilray's Deal is Tiny Compared to Canopy's

Chart of the Day, Part 2: Tilray's Deal is Tiny Compared to Canopy's

Perhaps no company has bought into the Canadian cannabis craze more than Constellation Brands.

Tilray Stock Burns Higher With Anheuser-Busch Beverage Deal

Tilray Stock Burns Higher With Anheuser-Busch Beverage Deal

Pot stock partnerships are a gateway to gains for cannabis investors.

Big Tobacco Hasn't Killed Cannabis, This Dance Has Only Just Begun

Big Tobacco Hasn't Killed Cannabis, This Dance Has Only Just Begun

After Altria's investment in Cronos Group, which cannabis company will be the next target?

Jim Cramer: What If Trump Tweets Xi Forced Him to Ignite the 25% Tariff Fuse?

Jim Cramer: What If Trump Tweets Xi Forced Him to Ignite the 25% Tariff Fuse?

Here are 4 stocks that can be bought into the stock cyclone that might occur if things don't go the bulls way in the Argentine.

Molson Coors Is Poised to Rally So Drink Up Responsibly

Molson Coors Is Poised to Rally So Drink Up Responsibly

When the markets get volatile it's time to circle back to defensive stocks.

Canopy Growth and 4 Other Cannabis Stocks That Look Good Here

Canopy Growth and 4 Other Cannabis Stocks That Look Good Here

These stocks offer some diversification or unique features in the legal-weed space.

Down the Marijuana Rabbit Hole: 5 Companies to Consider

It's too easy to lump all cannabis-related stocks into the moniker "marijuana." Like many other sectors, there are differentiators underneath the same way we see in semiconductors or retail or even energy.  As you go down the marijuana rabbit hole, ...

If You Must Trade Tilray, Use This Options Play: Market Recon

If You Must Trade Tilray, Use This Options Play: Market Recon

Covered calls may be the best bet -- or wait for a dip.

Experts Are High on Cannabis Stocks' 2019 Prospects

Experts Are High on Cannabis Stocks' 2019 Prospects

Expect more companies to join Coca-Cola, Molson Coors and Constellation Brands in checking out the market.

Aurora Cannabis Shares Surge as Coca-Cola Confirms CBD Interest

Aurora Cannabis Shares Surge as Coca-Cola Confirms CBD Interest

A tie-up between the two could mark the first major U.S. firm to establish a line of CBD drinks.

Coke's Flirtation with Cannabis Reaffirms What We Already Know

Coke's Flirtation with Cannabis Reaffirms What We Already Know

The latest reports about Coke looking into cannabis confirms a broader industry trend.

3 Big-Name Stocks to Consider Shorting

3 Big-Name Stocks to Consider Shorting

A brewer facing challenges, a banking giant and a retail behemoth are ripe for downside plays.

Cannabis for Traders, Cannabis for Investors: Market Recon

Cannabis for Traders, Cannabis for Investors: Market Recon

Not every cannabis stock was strong on Wednesday. One significant Canadian name sure was though.

Mainstream Research Just Doesn't Get Canopy Growth

Mainstream Research Just Doesn't Get Canopy Growth

Moody's and Zacks aren't seeing the potential for CBD drinks or even THC drinks.

Canada's Hexo Pursues Additional JV Cannabis Deals After Molson

Canada's Hexo Pursues Additional JV Cannabis Deals After Molson

Hexo is pursuing joint ventures in cosmetics, health care, candy, edibles, and vape companies.

Tilray Feeds Deal-Making Speculation on Analyst Call

Tilray Feeds Deal-Making Speculation on Analyst Call

Tilray reported a 95% jump in second-quarter revenue to $9.7 million, ahead of the Wall Street estimate of $9 million, in its first earnings release since it went public on July 19.